Conference
Access to personalized medicine: Factors influencing the use and value of gene expression profiling in treatment decision making.
Abstract
10
Background: Genomic information is increasingly used to personalize health care. One example is gene-expression profiling (GEP) tests that estimate recurrence risk to inform chemotherapy decisions in breast cancer treatment. Recently, GEP tests were publicly funded in Ontario. We assessed the clinical utility of GEP tests, exploring the factors facilitating their use and value in treatment decision-making. Methods: As part …
Authors
Bombard Y; Rozmovits L; Trudeau ME; Leighl NB; Deal K; Marshall D
Volume
31
Pagination
pp. 10-10
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
November 1, 2013
DOI
10.1200/jco.2013.31.31_suppl.10
Conference proceedings
Journal of Clinical Oncology
Issue
31_suppl
ISSN
0732-183X